Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
10394 Pacific Center Court, , San Diego, CA, 92121, US
The expansion adds state-of-the-art upstream and downstream GMP processing capabilities.
Released By Bora Biologics
The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing facility.
Bora Biologics is set to showcase its innovative Allosteric Formulation Platform at the Festival of Biologics 2025, demonstrating advancements in biologics development. This year’s conference is taking place at the San Diego Convention Center, April 23-24, 2025. Attendees are invited to visit Booth 632 to discover how Bora Biologics’ pioneering approaches can enhance biologics development. Pawel […]
Tanvex BioPharma, Inc. (“Tanvex“), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars products company, is pleased to announce the successful completion of its acquisition of Bora Biologics Co., Ltd. (“Bora Biologics“), a subsidiary of Bora Pharmaceuticals. Following this acquisition, Tanvex’s CDMO services will operate under the name Bora Biologics, continuing to be […]
The characterization of product-related variants in monoclonal antibodies involves identifying and quantifying the size and charge of variants that can impact..
In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.
Combining Tanvex’s biosimilar development expertise and U.S. FDA-licensed commercial-scale facility with Bora’s extensive global CDMO capabilities
FDA Approval of Nypozi™ and FDA BLA Acceptance of TX-05 Further Validates Tanvex's Expertise in Biologics Development and Manufacturing.
In the development of biosimilar products to Neulasta, it is essential to determine the intact molecular mass and confirm precise PEGylation sites.
Determination of PEGylated proteins' intact mass by mass spectrometry is challenging due to the molecules' large size, excessive charges, and more.
Monoclonal antibodies like Herceptin play a pivotal role in modern therapeutics, with their glycosylation patterns significantly influencing their bioactivity.
The quantitative measurement of potency plays a critical role in biopharmaceutical development.
Biotherapeutics comprise a diverse class of protein-based drugs with intricate structural and functional characteristics.
Biologic drugs must ensure that DNA from the host cell (hc) is below a recommended limit set by the FDA.
Rapid, Effective and Tailored Analytical Method Development
The temperature of chromatographic operations at manufacturing scale which utilize a chilled mobile phase can be difficult to replicate in a scale down model.
Drug formulation is one of the most critical aspects of the product life cycle from early clinical trials to commercial product launch.
Increasing afucosylation % of a monoclonal antibody by optimizing process parameters can enhance the efficacy of anticancer antibody therapeutics.
Tanvex launches Tanvex CDMO to provide comprehensive biologic contract development and manufacturing services to the biopharmaceutical industry
Small and mid-size biopharmaceutical companies need an experienced CDMO that can help them accelerate their products from concept to treatment more than ever
Will add upstream and downstream GMP processing capabilities to meet increasing demand for 2000L scale single-use biologics manufacturing.
By: Charlie Sternberg
The CDMO says the technology simplifies downstream processing for complex biologics.
By: Patrick Lavery
Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease.
By: Kristin Brooks
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
By: Adam Tuszyner
Will support pharmaceutical companies with formulation development, optimization, and lifecycle management of CM processes.
The independent assurance provider Det Norske Veritas conducted the validation.
Authorization clears the way for customers to enter Brazil’s $40 billion pharmaceutical market.
Will accelerate development and manufacturing of the innovative bispecific antibody for potential treatment of IBD.
The company will be focused on immune cell-targeting biologics and molecular glue payload-enabled antibody-drug conjugates.
Suitable for storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency medications.
With over 20 years of experience in the CDMO industry, Stevens has led high-performing teams across biologics, sterile, and drug-product manufacturing.
Establishes Zylidac Bio, a dedicated U.S.-based CDMO.
Enables global access to biotherapeutics utilizing Just – Evotec Biologics’ molecular design suite of computational technologies.
Forge to provide Ascidian with process and analytical development services, toxicology, and cGMP manufacturing.
ProBioGen to provide cell line development, process development, and GMP manufacturing for Zag Bio's lead ZAG-101 product candidate.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
